{"downloaded": true, "htmlmade": false, "full": {"id": "30958317", "source": "MED", "pmid": "30958317", "pmcid": "PMC6946688", "fullTextIdList": {"fullTextId": "PMC6946688"}, "doi": "10.3233/jpd-181549", "title": "Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.", "authorString": "Chuang YH, Lu AT, Paul KC, Folle AD, Bronstein JM, Bordelon Y, Horvath S, Ritz B.", "authorList": {"author": [{"fullName": "Chuang YH", "firstName": "Yu-Hsuan", "lastName": "Chuang", "initials": "YH", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Epidemiology, Fielding School of Public Health (FSPH), University of California Los Angeles (UCLA), Los Angeles, CA, USA."}}}, {"fullName": "Lu AT", "firstName": "Ake T", "lastName": "Lu", "initials": "AT", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA."}}}, {"fullName": "Paul KC", "firstName": "Kimberly C", "lastName": "Paul", "initials": "KC", "authorId": {"@type": "ORCID", "#text": "0000-0002-4476-2352"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Epidemiology, Fielding School of Public Health (FSPH), University of California Los Angeles (UCLA), Los Angeles, CA, USA."}}}, {"fullName": "Folle AD", "firstName": "Aline D", "lastName": "Folle", "initials": "AD", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Epidemiology, Fielding School of Public Health (FSPH), University of California Los Angeles (UCLA), Los Angeles, CA, USA."}}}, {"fullName": "Bronstein JM", "firstName": "Jeff M", "lastName": "Bronstein", "initials": "JM", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA."}}}, {"fullName": "Bordelon Y", "firstName": "Yvette", "lastName": "Bordelon", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA."}}}, {"fullName": "Horvath S", "firstName": "Steve", "lastName": "Horvath", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA."}, {"affiliation": "Department of Biostatistics, FSPH, UCLA, Los Angeles, CA, USA."}]}}, {"fullName": "Ritz B", "firstName": "Beate", "lastName": "Ritz", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Epidemiology, Fielding School of Public Health (FSPH), University of California Los Angeles (UCLA), Los Angeles, CA, USA."}, {"affiliation": "Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA."}, {"affiliation": "Department of Environmental Health, FSPH, UCLA, Los Angeles, CA, USA."}]}}]}, "authorIdList": {"authorId": {"@type": "ORCID", "#text": "0000-0002-4476-2352"}}, "dataLinksTagsList": {"dataLinkstag": ["related_data", "supporting_data", "altmetrics"]}, "journalInfo": {"issue": "2", "volume": "9", "journalIssueId": "2820165", "dateOfPublication": "2019", "monthOfPublication": "0", "yearOfPublication": "2019", "printPublicationDate": "2019-01-01", "journal": {"title": "Journal of Parkinson's disease", "ISOAbbreviation": "J Parkinsons Dis", "medlineAbbreviation": "J Parkinsons Dis", "NLMid": "101567362", "ISSN": "1877-7171", "ESSN": "1877-718X"}}, "pubYear": "2019", "pageInfo": "389-400", "abstractText": "<h4>Background</h4>DNA methylation studies in Parkinson's disease (PD) thus far have focused on disease susceptibility but not progression.<h4>Objective</h4>In this epigenome-wide association study (EWAS), we aim to identify methylation markers associated with faster cognitive decline or motor progression in PD.<h4>Methods</h4>We included 232 PD patients from the Parkinson's Environment and Gene follow-up study who provided blood samples at enrolment. Information on cognitive and motor function was collected using the Mini-Mental State Examination (MMSE) and Unified Parkinson's Disease Rating Scale (UPDRS). For EWAS analyses, we used a robust measure of correlation: biweight midcorrelations, t-tests, and Cox proportional hazard models. We also conducted weighted correlation network analysis (WGCNA) to identify CpG modules associated with cognitive decline or motor progression in PD.<h4>Results</h4>Among 197 individuals of European ancestry, with our EWAS approach we identified 7 genome-wide significant CpGs associated with a MMSE 4-point decline and 8 CpGs associated with faster motor progression (i.e., rate of UPDRS increase \u22655-point/year). The most interesting CpGs for cognitive decline include cg17445913 in KCNB1 (cor\u200a=\u200a0.36, p\u200a=\u200a6.85\u00d710-7) and cg02920897 in DLEU2 (cor\u200a=\u200a0.34, p\u200a=\u200a3.23\u00d710-6), while for motor progression it was cg01754178 in PTPRN2 (cor\u200a=\u200a- 0.34, p\u200a=\u200a2.07\u00d710-6). In WGCNA, motor progression related modules were enriched for genes related to neuronal synaptic functions, Wnt signaling pathway, and mitochondrial apoptosis.<h4>Conclusions</h4>Our study provides the first epigenetic evidence that differential methylation in genes previously identified as being associated with cognitive impairment, neuronal synaptic function, Wnt signaling pathway, and mitochondrial apoptosis is associated with cognitive and motor progression in PD.", "affiliation": "Department of Epidemiology, Fielding School of Public Health (FSPH), University of California Los Angeles (UCLA), Los Angeles, CA, USA.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "research-article", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"grantId": "P50 NS038367", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}, {"grantId": "R21 ES024356", "agency": "NIEHS NIH HHS", "acronym": "ES", "orderIn": "0"}, {"grantId": "F32 ES028087", "agency": "NIEHS NIH HHS", "acronym": "ES", "orderIn": "0"}, {"grantId": "R01 ES010544", "agency": "NIEHS NIH HHS", "acronym": "ES", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Synapses"}, {"majorTopic_YN": "N", "descriptorName": "Mitochondria"}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Parkinson Disease", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Disease Progression"}, {"majorTopic_YN": "N", "descriptorName": "Transferases", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Prognosis"}, {"majorTopic_YN": "N", "descriptorName": "Proportional Hazards Models"}, {"majorTopic_YN": "N", "descriptorName": "Longitudinal Studies"}, {"majorTopic_YN": "N", "descriptorName": "Apoptosis", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "DNA Methylation", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}, {"majorTopic_YN": "N", "descriptorName": "Shab Potassium Channels", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Receptor-Like Protein Tyrosine Phosphatases, Class 8", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Wnt Signaling Pathway", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Cognitive Dysfunction", "meshQualifierList": {"meshQualifier": {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "Y", "descriptorName": "Epigenome"}]}, "keywordList": {"keyword": ["DNA methylation", "Longitudinal Studies", "Parkinson\u2019s Disease", "Disease Progression", "Cognitive Decline", "Mmse", "Updrs"]}, "chemicalList": {"chemical": [{"name": "PTPRN2 protein, human", "registryNumber": "EC 3.1.3.48"}, {"name": "KCNB1 protein, human", "registryNumber": "0"}, {"name": "Shab Potassium Channels", "registryNumber": "0"}, {"name": "Transferases", "registryNumber": "EC 2.-"}, {"name": "Receptor-Like Protein Tyrosine Phosphatases, Class 8", "registryNumber": "EC 3.1.3.48"}, {"name": "DLEU2 lncRNA, human", "registryNumber": "0"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/JPD-181549"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6946688"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6946688?pdf=render"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/jpd-181549"}]}, "isOpenAccess": "N", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "5", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "Y", "dbCrossReferenceList": {"dbName": "EMBL"}, "hasLabsLinks": "Y", "authMan": "Y", "epmcAuthMan": "N", "nihAuthMan": "Y", "manuscriptId": "NIHMS1058418", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": ["geo", "refsnp", "go"]}, "dateOfCompletion": "2020-04-27", "dateOfCreation": "2019-04-09", "firstIndexDate": "2019-04-11", "fullTextReceivedDate": "2020-10-21", "dateOfRevision": "2021-03-11", "firstPublicationDate": "2019-01-01"}, "abstract": "<h4>Background</h4>DNA methylation studies in Parkinson's disease (PD) thus far have focused on disease susceptibility but not progression.<h4>Objective</h4>In this epigenome-wide association study (EWAS), we aim to identify methylation markers associated with faster cognitive decline or motor progression in PD.<h4>Methods</h4>We included 232 PD patients from the Parkinson's Environment and Gene follow-up study who provided blood samples at enrolment. Information on cognitive and motor function was collected using the Mini-Mental State Examination (MMSE) and Unified Parkinson's Disease Rating Scale (UPDRS). For EWAS analyses, we used a robust measure of correlation: biweight midcorrelations, t-tests, and Cox proportional hazard models. We also conducted weighted correlation network analysis (WGCNA) to identify CpG modules associated with cognitive decline or motor progression in PD.<h4>Results</h4>Among 197 individuals of European ancestry, with our EWAS approach we identified 7 genome-wide significant CpGs associated with a MMSE 4-point decline and 8 CpGs associated with faster motor progression (i.e., rate of UPDRS increase \u22655-point/year). The most interesting CpGs for cognitive decline include cg17445913 in KCNB1 (cor\u200a=\u200a0.36, p\u200a=\u200a6.85\u00d710-7) and cg02920897 in DLEU2 (cor\u200a=\u200a0.34, p\u200a=\u200a3.23\u00d710-6), while for motor progression it was cg01754178 in PTPRN2 (cor\u200a=\u200a- 0.34, p\u200a=\u200a2.07\u00d710-6). In WGCNA, motor progression related modules were enriched for genes related to neuronal synaptic functions, Wnt signaling pathway, and mitochondrial apoptosis.<h4>Conclusions</h4>Our study provides the first epigenetic evidence that differential methylation in genes previously identified as being associated with cognitive impairment, neuronal synaptic function, Wnt signaling pathway, and mitochondrial apoptosis is associated with cognitive and motor progression in PD.", "Keywords": ["DNA methylation", "Longitudinal Studies", "Parkinson\u2019s Disease", "Disease Progression", "Cognitive Decline", "Mmse", "Updrs"], "journaltitle": "Journal of Parkinson's disease", "authorinfo": ["Chuang YH", "Lu AT", "Paul KC", "Folle AD", "Bronstein JM", "Bordelon Y", "Horvath S", "Ritz B"], "title": "Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease."}